Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Given its low valuation and the seeming overreaction in the markets to the recent trial results, this is a stock that could ...

Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

This time last year, people were still bickering about whether Novo Nordisk's Wegovy and Eli Lilly & Co.'s Zepbound represented a shortcut to losing weight or a medical breakthrough. But with reams of ...

Lisa Jarvis In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish ...

With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...